| Anti-Allergic Range |
| 1. Alcaftadine 0.25% w/v Ophthalmic Solution |
| 2. Bepotastine Besilate 1.5% w/v Ophthalmic Solution |
| 3. Olopatadine Hydrochloride Ophthalmic Solution 0.1% w/v |
| 4. Olopatadine Hydrochloride Ophthalmic Solution 0.2% w/v |
| 5. Olopatadine Hydrochloride Ophthalmic Solution 0.7% w/v (BKC Free) |
| 6. Olopatadine 0.1% w/v and Ketorolac Tromethamine 0.4% w/v Ophthalmic Solution |
| 7. Loteprednol Etabonate Ophthalmic Suspension 0.2% w/v |
| 8. Sodium Cromoglicate Ophthalmic Solution 2% w/v |
| |
| Anti-Glaucoma Range |
| 1. Brimonidine Tartrate 0.2% w/v + Timolol 0.5% w/v Ophthalmic Solution |
| 2. Brimonidine Tartrate 0.2% w/v + Timolol 0.5% w/v Ophthalmic Solution with Ionic Buffer |
| 3. Brimonidine Tartrate 0.15% w/v + Timolol 0.5% w/v Ophthalmic Solution with Ionic Buffer |
| 4. Brimonidine Tartrate 0.2% w/v Ophthalmic Solution |
| 5. Timolol Maleate 0.5% w/v Ophthalmic Solution |
| 6. Travoprost 0.004% w/v Ophthalmic Solution (Preservative Free) |
| 7. Travoprost 0.004% w/v + Timolol 0.5% w/v Ophthalmic Solution with Ionic Buffer |
| 8. Bimatoprost 0.01% w/v Ophthalmic Solution |
| 9. Brinzolamide 1% w/v Ophthalmic Suspension |
| 10. Brinzolamide + Brimonidine Tartrate Ophthalmic Suspension |
| 11. Brinzolamide + Timolol Ophthalmic Suspension |
| 12. Dorzolamide 2% w/v Ophthalmic Solution |
| 13. Dorzolamide 2% w/v + Timolol 5% w/v Ophthalmic Solution |
| |
| Anti-Infective Range |
| 1. Moxifloxacin 0.5% w/v Ophthalmic Solution |
| 2. Gatifloxacin 0.3% w/v Ophthalmic Solution |
| 3. Gatifloxacin 0.5% w/v Ophthalmic Solution |
| 4. Besifloxacin 0.6% w/v Ophthalmic Solution |
| 5. Tobramycin 0.3% w/v Ophthalmic Solution |
| 6. Ciprofloxacin 0.3% w/v Ophthalmic Solution |
| 7. Chloramphenicol 0.5% w/v Ophthalmic Solution |
| 8. Ofloxacin 0.3% w/v Ophthalmic Solution |
| |
| Anti-Infective + NSAIDs Combinations |
| 1. Moxifloxacin 0.5% w/v + Ketorolac Tromethamine 0.5% w/v Ophthalmic Solution |
| 2. Moxifloxacin 0.5% w/v + Ketorolac Tromethamine 0.4% w/v Ophthalmic Solution |
| 3. Moxifloxacin 0.5% w/v + Bromfenac 0.09% w/v Ophthalmic Solution |
| 4. Ofloxacin 0.3% w/v + Ketorolac 0.5% w/v Ophthalmic Solution |
| |
| Anti-Infective + Steroidal Anti-Inflammatory Combinations |
| 1. Moxifloxacin 0.5% w/v + Dexamethasone Phosphate 0.1% w/v Ophthalmic Solution |
| 2. Ofloxacin 0.3% w/v + Dexamethasone Phosphate 0.1% w/v Ophthalmic Solution |
| 3. Moxifloxacin 0.5% w/v + Loteprednol Etabonate 0.5% w/v Ophthalmic Suspension (Preservative Free) |
| 4. Moxifloxacin 0.5% w/v + Prednisolone Acetate 1% w/v Ophthalmic Suspension |
| 5. Gatifloxacin 0.3% w/v + Dexamethasone Phosphate 0.1% w/v Ophthalmic Solution |
| 6. Loteprednol Etabonate 0.5% w/v + Tobramycin 0.3% w/v Ophthalmic Suspension |
| 7. Tobramycin Sulfate 0.3% w/v + Fluoromethalone 0.1% w/v Ophthalmic Suspension |
| 8. Tobramycin Sulfate 0.3% w/v + Dexamethasone Sodium Phosphate 0.1% w/v Ophthalmic Solution |
| 9. Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v Ophthalmic Emulsion |
| 10. Polymyxin-B Sulfate 5000IU + Chloramphenicol 0.4% w/v + Dexamethasone Sodium Phosphate 0.1% w/v Eye/Ear Drops |
| |
| Dry Eyes Range |
| 1. Sodium Carboxymethylcellulose 0.5% w/v Ophthalmic Solution |
| 2. Carboxymethylcellulose 0.5% Ophthalmic Solution (Preserved with Ionic Buffer) |
| 3. Sodium Carboxymethylcellulose 1% w/v Ophthalmic Solution |
| 4. Sodium Carboxymethylcellulose 0.5% w/v + Glycerin 0.5% w/v Ophthalmic Solution |
| 5. Sodium Carboxymethylcellulose 1.0% w/v + Glycerin 0.5% w/v Ophthalmic Solution |
| 6. Sodium Hyaluronate 0.1% w/v Ophthalmic Solution |
| 7. Sodium Hyaluronate 0.1% w/v Ophthalmic Solution + Trehalose (excipient) |
| 8. Sodium Hyaluronate 0.18% Ophthalmic Solution + Stabilized Oxychloro Complex (with Trehalose, Erythritol, CMC, Glycerin and Vitamin D3 as excipients) |
| 9. Sodium Hyaluronate 0.18% w/v + Stabilized Oxychloro Complex (Preservative) Ophthalmic Solution |
| 10. Sodium Hyaluronate 0.18% + Stabilized Oxychloro Complex (Preservative) Ophthalmic Solution + Trehalose (excipient) |
| 11. D-Panthenol 5% w/v + Sodium Hyaluronate 0.1% w/v Ophthalmic Solution |
| 12. Sodium Hyaluronate 0.3% w/v Ophthalmic Solution |
| 13. PEG 400 0.4% w/v + Propylene Glycol 0.3% w/v + Stabilized Oxychloro Complex (Preservative) Ophthalmic Solution |
| 14. PEG 400 0.4% w/v + Propylene Glycol 0.3% w/v (Preservative Free) Ophthalmic Solution |
| 15. Hydroxypropylmethylcellulose 0.3% w/v Ophthalmic Solution |
| 16. Hydroxypropylmethylcellulose 0.3% w/v + Dextran 0.1% w/v + Glycerin 0.2% w/v Ophthalmic Solution |
| 17. Polyvinyl Alcohol 1.4% w/v + Povidone 0.6% w/v Ophthalmic Solution |
| 18. Sodium Hyaluronate, Polyethylene Glycol 400 and Propylene Glycol Lubricant Eye Drops, Sodium Hyaluronate 0.18% (Preserved with Ionic Buffer) with Omega 3 and Osmoprotectants as excipients |
| |
| Mydriatics and Cycloplegics |
| 1. Tropicamide 0.8% w/v + Phenylephrine 5% w/v Ophthalmic Solution |
| 2. Tropicamide 1% w/v Ophthalmic Solution |
| 3. Cyclopentolate Hydrochloride 1% w/v Ophthalmic Solution |
| |
| Non-Steroidal Anti-Inflammatory Range |
| 1. Nepafenac Ophthalmic Suspension 0.1% w/v |
| 2. Nepafenac Ophthalmic Suspension 0.3% w/v |
| 3. Nepafenac Ophthalmic Solution 0.1% w/v |
| 4. Flurbiprofen Sodium 0.03% w/v + HPMC 0.25% w/v Ophthalmic Solution |
| 5. Bromfenac 0.09% w/v Ophthalmic Solution |
| 6. Bromfenac 0.09% Ophthalmic Solution (Preserved with Ionic Buffer) |
| 7. Ketorolac Tromethamine 0.4% w/v Ophthalmic Solution |
| |
| Soothing Agents |
| 1. Naphazoline Hydrochloride + Phenylephrine Hydrochloride + Menthol + Camphor + HPMC + Chlorpheniramine Maleate Ophthalmic Solution |
| 2. Naphazoline Hydrochloride + Borax + Boric Acid + HPMC + Menthol + Camphor Ophthalmic Solution |
| |
| Steroidal Anti-Inflammatory Range |
| 1. Loteprednol Etabonate 0.5% w/v Ophthalmic Suspension |
| 2. Prednisolone 1% w/v Ophthalmic Suspension |
| 3. Fluoromethalone 0.1% w/v Ophthalmic Solution |
| |
| Other Ranges |
| 1. Sodium Chloride 5% w/v Ophthalmic Solution |
| 2. Potassium Iodide 3.3% w/v + Sodium Chloride 0.83% w/v + Calcium Chloride 1.325% w/v Ophthalmic Solution |